Home Compare IPN.PA vs ZTS
Stock Comparison · Industry comparison · Drug Manufacturers - Specialty

Ipsen vs Zoetis: Which Stock Looks Stronger in 2026?

Zoetis holds the cleaner structural position, with the lead spread across valuation and profitability. Ipsen still leads on growth and stability, which keeps the comparison from looking entirely one-sided. In the market, Ipsen carries the stronger setup — intact trend against Zoetis's broken trend. That leaves a split case: the structural lead stays with Zoetis, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead is spread across valuation and profitability, rather than sitting in one isolated gap. The overall score gap is 9 points in favour of Zoetis Inc..

INDUSTRY COMPARISON

Both operate in: Drug Manufacturers - Specialty & Generic

This comparison is based on industry proximity, not on functional trajectory similarity. IPN.PA and ZTS share the same industry classification.

For a similarity-based comparison, see how Ipsen and Zoetis each position within their functional peer groups in AssetNext.

Peer-Relative Score
IPN.PA
Ipsen S.A.
50
Peer-Score
Signal qualityMedium
vs
ZTS
Zoetis Inc.
59
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: IPN.PA vs ZTS Profitability 51 85 Stability 57 23 Valuation 43 82 Growth 51 20 IPN.PA ZTS
Gap Ranking
#1 Valuation +39
#2 Profitability +34
#3 Stability +34
#4 Growth +31
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for IPN.PA and ZTS Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer IPN.PAZTS Relative valuation Structural strength

Ipsen S.A. holds the stronger structural profile, but the price setup still leans toward Zoetis Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Valuation
Both rank well on valuation, but Zoetis Inc. still holds a clear edge.
Profitability
On profitability, the edge is clear — both rank well, but Zoetis Inc. sits noticeably higher.
Valuation — Dominant Gap
IPN.PA
43
ZTS
82
Gap+39in favour of ZTS

The multiple-based pricing edge comes from a trailing P/E that is 11.8 turns lower.

What keeps the gap from being one-sided

Stability still tilts materially toward Ipsen S.A., which stops the result from looking dominant across the whole profile.

What this means for the comparison

The lead is built on both valuation and profitability — though growth still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the IPN.PA vs ZTS comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how IPN.PA and ZTS each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.